Meme Stock Alert: Why Tilray Brands (TLRY) Could Be the Next Wall Street Sensation

Tilray Brands (TLRY) has seen a significant surge, fueled by speculation around U.S. marijuana reclassification, sector-wide rallies, and an active options market. TLRY has a market cap of $700M and annual sales nearing $800M, making it an attractive contrarian retail trader pick. The stock has a healthy options market, rising implied volatility, and has been spotted by the Market on Close team as a potential meme stock breakout.

Tilray Brands (TLRY) experienced a significant surge in its stock price on July 2, 2025, fueled by speculation around potential federal-level reclassification of marijuana. The company's shares jumped by nearly 38.5% in the afternoon session, following reports that U.S. President Donald Trump is considering reclassifying marijuana as a less dangerous drug [3].

The potential reclassification could transform the cannabis industry's regulatory landscape by easing federal restrictions. Marijuana is currently classified as a Schedule I substance under the Controlled Substances Act, which has a high potential for abuse and no current accepted medical use. Reclassification could remove this classification, allowing for greater access to banking services, attracting institutional investors, and potentially leading to mergers and acquisitions [1].

One of the key benefits of reclassification would be the removal of the Internal Revenue Code Section 280E tax burden. This section prohibits cannabis companies from taking normal business deductions, significantly impacting their profitability. Resolution of this tax barrier could pave the way for cannabis companies to list on U.S. stock exchanges, further unlocking capital-market access [1].

The market's reaction to these developments highlights the potential impact of political and regulatory changes on corporate performance. Investors are closely watching these shifts, and the success of Tilray and other cannabis companies will depend on how these changes play out over time.

Tilray's stock has been particularly volatile, with 59 moves greater than 5% over the last year. However, the recent move was notable due to its size and the significant impact it had on the market's perception of the business. The stock has been down 34.2% since the beginning of the year and is currently trading at $0.96 per share, 50.8% below its 52-week high of $1.95 from August 2024 [3].

The options market has been active around Tilray, with traders acquiring a large volume of put options on the stock. This indicates a significant level of interest and uncertainty among investors regarding the company's future prospects [4].

Institutional investors and hedge funds have also been active in Tilray's stock, with several recently adding to or reducing their stakes. Lido Advisors LLC, Cerity Partners LLC, Capital Management Associates Inc, Fifth Lane Capital LP, and Zuckerman Investment Group LLC are among the institutions that have increased their holdings in Tilray [4].

Despite the recent surge, analysts have mixed ratings on Tilray, with an average rating of "Hold" and a price target of $1.92. Wall Street Zen downgraded Tilray to a "strong sell" rating, while Roth Capital and Zelman & Associates maintained a "neutral" rating [4].

The market's reaction to Tilray's surge and the broader cannabis sector's rally highlights the potential impact of political and regulatory changes on corporate performance. Investors are closely watching these shifts, and the success of Tilray and other cannabis companies will depend on how these changes play out over time.

References:
[1] https://www.theglobeandmail.com/business/article-cannabis-stocks-trump-reclassification/
[2] https://www.ainvest.com/news/intel-ceo-receives-support-trump-controversy-tilray-brands-surges-reclassification-rumors-2508/
[3] https://finance.yahoo.com/news/why-tilray-tlry-stock-soaring-204543868.html
[4] https://www.marketbeat.com/instant-alerts/traders-purchase-large-volume-of-tilray-brands-put-options-nasdaqtlry-2025-08-05/